Renesas Announces Consolidated Forecasts
TOKYO–(BUSINESS WIRE)–#ConsolidatedForecasts–Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions,... Read more.
Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
Revenue Growth of +6.4% at Actual Exchange Rate (AER); +1.4% Growth at Constant Exchange Rate (CER), Driven by Growth & Launch Products (+13% at CER) Core Operating... Read more.
Successful Entry Into Service of the EUTELSAT KONNECT VHTS Satellite, Driving Connectivity Growth
One of the most advanced satellites delivering fixed, mobile, and government connectivity across Europe. 500 Gbps of capacity making it the largest ever European... Read more.
MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial in Acute Graft-versus-Host Disease with MaaT013
The independent Data Safety Monitoring Board (DSMB), after careful review of safety, efficacy, and protocol adherence, has unanimously recommended that the trial... Read more.
Axway Software: Strong Revenue Performance in Q3 2023
Quarterly revenue up 11.3% organically1 and 2.7% overall Annual Recurrent Revenue (ARR) of €202.5m, up 10.4% on end-September 2022 Subscription activity revenue... Read more.
Mercedes-Benz Group Solid Q3 Results Underscore Resilience in a Subdued Market Environment
Performance: Q3 adjusted Return on Sales (RoS) reaches 12.4% (Q3 2022: 14.5%) at Mercedes-Benz Cars and 15.0% at Mercedes-Benz Vans (Q3 2022: 12.7%); adjusted Return... Read more.
Carbios Obtains Building and Operating Permits, in Line With Announced Schedule, for World’s First PET Biorecycling Plant in Longlaville
The simultaneous acquisition of the building permit and operating authorization allows construction work to start as planned for the plant’s commissioning... Read more.
Galderma Phase III Data Published in the New England Journal of Medicine: Full OLYMPIA 2 Trial Results Demonstrate Nemolizumab’s Rapid Onset of Action in Prurigo Nodularis Patients
The phase III OLYMPIA 2 trial in patients with prurigo nodularis met all primary and key secondary endpoints, showing nemolizumab monotherapy significantly and rapidly... Read more.
Ryan Gosling Tops McAfee’s 2023 Hacker Celebrity Hot List
McAfee Labs reveals the big-name celebrities whose names are most often exploited by scammers to lead you to malware or risky sites when searching online Canadian... Read more.
Gravity Officially Launches New Roguelike Game Wetory on Nintendo Switch and Steam
SEOUL, South Korea–(BUSINESS WIRE)–#GRVY—Gravity (NASDAQ: GRVY), a global game company, officially launched its new roguelike game, Wetory, on... Read more.